Ischemic stroke will lead modulated aspiration device sales through 2036 with 56.0% share in 2026. Pressure modulation holds 48.0% of technology demand. The market stands at USD 185.0 million in 2026 and is set to reach USD 430.0 million by 2036 as thrombectomy volumes rise across stroke centres.